Sponsors (2)
The bill would expand early vision screening, surveillance, and research to reduce preventable vision loss and address disparities, but it would require new public spending and infrastructure investments and may leave gaps in coverage for Medicare beneficiaries.
Children (including non‑Hispanic Black children at higher risk) and adults with diabetes would receive earlier, prioritized vision screening, referral, and follow‑up, reducing preventable vision loss and improving school readiness and long‑term independence.
A national surveillance system and integrated screening would improve tracking of vision disorders and disparities, enabling targeted interventions to reduce inequities in eye health.
Federal investment in vision research could accelerate development of advanced treatments (e.g., gene therapies, regenerative medicine), potentially improving outcomes and yielding long‑term cost savings compared with treating advanced vision loss.
Expanding screening, surveillance, and research would increase federal and state healthcare spending, raising costs for taxpayers and potentially pressuring state budgets.
Increased screening and referral activity could strain provider capacity (FQHCs, ophthalmology practices) and require workforce and infrastructure expansion, creating potential delays in care unless capacity is expanded.
Because Medicare typically excludes routine vision coverage, many seniors and Medicare beneficiaries may still face out‑of‑pocket costs for vision care unless benefits are changed, limiting access for low‑income older adults.
Based on analysis of 2 sections of legislative text.
Recognizes high prevalence and preventability of vision loss, documents gaps in screening, coverage, surveillance, and research, and calls for prevention, early detection, access, and increased research.
Introduced February 26, 2026 by Marc Veasey · Last progress February 26, 2026
Recognizes the high and growing burden of vision impairment and blindness globally and in the United States, highlights that most vision loss is preventable or treatable, and calls attention to gaps in screening, access, coverage, surveillance, and research. It emphasizes diabetes as a leading cause of adult blindness, unequal impacts on children and racial groups, limits in routine vision coverage under Medicare, and the cost-effectiveness of prevention and early treatment. Summarizes evidence and urges attention to prevention, early detection, timely referral and follow-up, improved access to care, better national surveillance, and increased research investment to reduce avoidable vision loss and its social and economic costs.